Fin Trust Capital Advisors, LLC Fulgent Genetics, Inc. Transaction History

Fin Trust Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$47.98 - $62.75 $479 - $627	-10 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $773 - $1,050	10 New	10 $1,000
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $41,510 - $128,695	-700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $18,916 - $31,781	610 Added 677.78%	700 $36,000
Q3 2020 Nov 10, 2020	BUY	$15.89 - $50.51 $1,430 - $4,545	90 New	90 $4,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $512M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.